The only cardiovascular risk calculator that incorporates your coronary artery calcium (CAC) score. Get your 10-year CHD risk and Coronary Age using the validated 2015 MESA equations.
McClelland RL et al., JACC 2015 Β· Ages 45β85 Β· CAC score optional
If you have had a coronary CT scan, enter your CAC score. A score of 0 dramatically reduces risk. Leave blank to calculate using traditional risk factors only.
The MESA CHD Risk Score was published by McClelland RL et al. in the Journal of the American College of Cardiology in 2015. It was derived from the Multi-Ethnic Study of Atherosclerosis β a prospective cohort of 6,814 participants aged 45β84, free of clinical heart disease at baseline, followed for 10 years across six U.S. field centers.
The MESA calculator is unique among cardiovascular risk tools because it incorporates coronary artery calcium (CAC) score as an optional input. When CAC is included, the model's C-statistic improves from 0.75 to 0.80 β a clinically meaningful improvement that allows accurate reclassification of borderline-risk patients up or down based on their actual plaque burden.
The only validated calculator that incorporates coronary artery calcium score. A CAC=0 can reclassify intermediate-risk patients to low risk; a high CAC can do the opposite.
Translates your risk into the biological age of your heart β more intuitive than a percentage, and powerful for motivating lifestyle changes.
Unlike ASCVD and PREVENT, MESA includes family history of MI as a validated coefficient β reflecting the genetic contribution to CHD risk.
The clinical power of the MESA calculator lies in how dramatically the CAC score can shift risk estimates in both directions:
Coronary Age was derived by Blaha MJ et al. from the MESA study and published in the Journal of the American Heart Association in 2021. The concept asks: at what age would an average healthy person have the same 10-year CHD risk as you currently have? The "average healthy person" is defined using reference cardiovascular risk factor values from the MESA cohort β normal blood pressure, normal cholesterol, no diabetes, no smoking, and no family history.
If your Coronary Age is significantly higher than your actual age, it means your risk factor burden is aging your cardiovascular system faster than the calendar. If your Coronary Age is lower, your heart is biologically younger than your chronological age. Clinical experience suggests Coronary Age is often more motivating for patients than a risk percentage β telling someone their heart is 12 years older than their body tends to prompt action more effectively than saying "your risk is 14%."
A CAC score of zero means no detectable calcified plaque in your coronary arteries β and it is the strongest available negative predictor of cardiovascular events. Even patients with borderline or intermediate traditional risk scores (5β15%) can reasonably defer statin therapy when CAC=0, per 2018 ACC/AHA guidelines. CAC=0 is associated with a very low 10-year event rate, often below 2%, regardless of traditional risk factor burden.
Without CAC, the MESA Risk Score achieves a C-statistic of approximately 0.75 β similar to other validated cardiovascular risk tools. When CAC score is included, this improves to 0.80. External validation in the Heinz Nixdorf Recall Study (Germany) and Dallas Heart Study confirmed good discrimination and calibration in independent cohorts outside the United States.
Yes β the without-CAC version uses traditional risk factors (age, sex, race, cholesterol, blood pressure, diabetes, smoking, family history) and produces a validated 10-year CHD risk estimate. The Coronary Age calculation also works without CAC. The CAC input simply upgrades accuracy when available.
A coronary calcium scan is a non-invasive CT scan available at most hospitals and imaging centers. It takes about 10 minutes with no contrast injection and delivers a small radiation dose. Cost is typically $100β$400 and is sometimes covered by insurance. The 2018 ACC/AHA guidelines recommend it for borderline-risk adults (ASCVD 5β20%) where the statin decision is uncertain.